<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Sexually transmitted infections: Issues specific to adolescents</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Sexually transmitted infections: Issues specific to adolescents</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Sexually transmitted infections: Issues specific to adolescents</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">J Dennis Fortenberry, MD, MS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 18, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>This topic will focus on aspects of sexually transmitted infections (STIs) that are particularly relevant in adolescents. Details about clinical manifestations, diagnosis, and treatment of individual infections are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span><em>Chlamydia trachomatis</em> (see  <a class="medical medical_review" href="/d/html/83019.html" rel="external">"Clinical manifestations and diagnosis of <i>Chlamydia trachomatis </i>infections"</a> and  <a class="medical medical_review" href="/d/html/7579.html" rel="external">"Treatment of <i>Chlamydia trachomatis</i> infection"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Neisseria gonorrhoeae</em> (see  <a class="medical medical_review" href="/d/html/15893.html" rel="external">"Clinical manifestations and diagnosis of <i>Neisseria gonorrhoeae </i>infection in adults and adolescents"</a> and  <a class="medical medical_review" href="/d/html/15892.html" rel="external">"Treatment of uncomplicated gonorrhea (<i>Neisseria gonorrhoeae </i>infection) in adults and adolescents"</a> and  <a class="medical medical_review" href="/d/html/7603.html" rel="external">"Disseminated gonococcal infection"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Syphilis (see  <a class="medical medical_review" href="/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV"</a> and  <a class="medical medical_review" href="/d/html/7588.html" rel="external">"Syphilis: Screening and diagnostic testing"</a> and  <a class="medical medical_review" href="/d/html/4794.html" rel="external">"Syphilis in pregnancy"</a> and  <a class="medical medical_review" href="/d/html/7597.html" rel="external">"Syphilis: Treatment and monitoring"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Human immunodeficiency virus (HIV) (see  <a class="medical medical_review" href="/d/html/86984.html" rel="external">"Acute and early HIV infection: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/3717.html" rel="external">"Acute and early HIV infection: Treatment"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Herpes simplex virus (see  <a class="medical medical_review" href="/d/html/8347.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection"</a> and  <a class="medical medical_review" href="/d/html/8346.html" rel="external">"Treatment of genital herpes simplex virus infection"</a> and  <a class="medical medical_review" href="/d/html/8340.html" rel="external">"Genital herpes simplex virus infection and pregnancy"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chancroid (see  <a class="medical medical_review" href="/d/html/7582.html" rel="external">"Chancroid"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pubic lice (see  <a class="medical medical_review" href="/d/html/4037.html" rel="external">"Pediculosis pubis and pediculosis ciliaris"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Trichomonas vaginalis</em> (see  <a class="medical medical_review" href="/d/html/5453.html" rel="external">"Trichomoniasis: Clinical manifestations and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Condylomata acuminata (see  <a class="medical medical_review" href="/d/html/99981.html" rel="external">"Condylomata acuminata (anogenital warts) in adults: Epidemiology, pathogenesis, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/5458.html" rel="external">"Condylomata acuminata (anogenital warts): Treatment of vulvar and vaginal warts"</a> and  <a class="medical medical_review" href="/d/html/99984.html" rel="external">"Condylomata acuminata (anogenital warts): Management of external condylomata acuminata in adult males"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Mycoplasma genitalium</em> (see  <a class="medical medical_review" href="/d/html/83202.html" rel="external">"<i>Mycoplasma genitalium</i> infection"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lymphogranuloma venereum (see  <a class="medical medical_review" href="/d/html/7593.html" rel="external">"Lymphogranuloma venereum"</a>)</p><p></p><p class="headingAnchor" id="H1470172651"><span class="h1">ADOLESCENT SEXUAL DEVELOPMENT</span><span class="headingEndMark"> — </span>Normal adolescent psychosocial development encompasses a desire for autonomy and an increase in risk-taking behaviors, making adolescents particularly vulnerable to STIs. (See  <a class="medical medical_review" href="/d/html/113.html" rel="external">"Sexual development and sexuality in children and adolescents", section on 'Adolescent development'</a>.)</p><p>Early adolescence begins during the first years of the second decade and is marked by rapid physical growth and attainment of secondary sex characteristics.</p><p>Middle adolescence begins at approximately age 14 years, ends around age 17 to 18 years, and is marked by maturation of the reproductive systems and achievement of adult physical stature. Increased sexual interest and noncoital sexual behaviors are characteristic of middle adolescence. The average age of first coitus is approximately 16 years among American adolescents, but the age is lower in certain populations.</p><p>Late adolescence ends with the transition into young adulthood and is associated with high levels of sexual activity and acquisition of STIs.</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>STIs are common in adolescents. <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fstd%2Fstatistics%2F&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLLB7P5JePSk9VhHpB%2BUI9loiwZtrdQ1sXBCGKGWTWmlc&amp;TOPIC_ID=115" target="_blank">Surveillance in the United States</a> suggests that approximately two-thirds of incident chlamydia infections and one-half of incident gonococcal infections occur in adolescents and young adults (age 15 to 24 years) [<a href="#rid1">1</a>].</p><p>Between 2019 and 2020, rates of genital gonorrhea increased, rates of genital chlamydia decreased, and rates of primary and secondary syphilis decreased among male and increased among female adolescents (age 15 to 19 years) [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Genital gonorrhea – From 329 to 369 cases per 100,000 population in males and from 560 to 616 cases per 100,000 population in females</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Genital chlamydia – From 1012 to 846 per 100,000 population in males and from 3338 to 2858 cases per 100,000 in females</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Primary and secondary syphilis – From 11.2 to 10.9 per 100,000 population in males and from 4.9 to 5.9 cases per 100,000 population in females</p><p></p><p>Repeated acquisition of STIs is common: As many as 40 percent of the annual incidence of chlamydial or gonococcal disease occurs in adolescents previously infected with the causative organisms, and this proportion may be increasing [<a href="#rid3">3</a>]. Many adolescents are reinfected within a few months of an index infection [<a href="#rid4">4,5</a>]. (See <a class="local">'Reinfection'</a> below.)</p><p>Repeated acquisition of STIs is a risk factor for subsequent development of HIV infection. In a retrospective cohort of 75,273 high school students who participated in an STI screening program between 2003 and 2010, 248 students (0.3 percent) tested positive for HIV [<a href="#rid6">6</a>]. The risk of HIV infection was at least three times higher in students with multiple gonococcal infections than students with no history of gonorrhea (incidence rate ratio [IRR] 3.5, 95% CI 1.9-6.4 for females and IRR 5.1, 95% CI 3.6-7.1 for males). Among HIV-positive students, there was at least one year between the first STI and positive HIV test for 86 percent of females and 96 percent of males, suggesting a window of opportunity for preventive interventions.</p><p>Among adolescents, HIV infection is primarily transmitted sexually, although it may be transmitted by other routes (eg, injection drug use, blood products). Adolescent HIV is discussed separately. (See  <a class="medical medical_review" href="/d/html/6007.html" rel="external">"The adolescent with HIV infection"</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">RISK FACTORS</span></p><p class="headingAnchor" id="H4"><span class="h2">Behavioral</span><span class="headingEndMark"> — </span>Behavioral factors have been linked to the increased risk of acquisition of STIs among adolescents, but biologic factors also may play a role.</p><p>Behavioral factors that have been associated with acquisition of STIs in adolescents include [<a href="#rid5">5,7-11</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Time elapsed since first intercourse, particularly for human papillomavirus (HPV). In an observational study of urban females (14 to 17 years at enrollment), 25 percent were diagnosed with an STI within one year of first intercourse [<a href="#rid5">5</a>]. Repeated infections were common. These findings highlight the need for initiation of STI screening within one year of first intercourse and of retesting individuals who have been infected every three to four months. (See  <a class="medical medical_review" href="/d/html/7596.html" rel="external">"Screening for sexually transmitted infections"</a> and  <a class="medical medical_review" href="/d/html/15892.html" rel="external">"Treatment of uncomplicated gonorrhea (<i>Neisseria gonorrhoeae </i>infection) in adults and adolescents", section on 'Retesting'</a> and  <a class="medical medical_review" href="/d/html/7579.html" rel="external">"Treatment of <i>Chlamydia trachomatis</i> infection", section on 'Retesting for all patients'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sexual activity within early and middle adolescence, particularly for <em>C. trachomatis</em> infection [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multiple partners, new partners, or partners with multiple other partners [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For male or transgender female adolescents: having sex with a person with a penis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inconsistent use of condoms, especially with established partners.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alcohol and other drug consumption (although this factor may be associated with multiple partners, condomless sex, or sex with a high-risk partner) rather than serving as an independent marker of risky behavior) [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rectal douching or enemas in preparation for receptive anal sex (may break down the rectal mucosal barrier) [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Receiving or sending sexually explicit messages ("sexting") is reported by approximately 20 percent of youth in the United States [<a href="#rid15">15</a>] and linked to sexual activities such as new partner acquisition and sex without a condom [<a href="#rid16">16</a>]; however, sexting has not been directly linked to increased STI risk. </p><p></p><p>Surveys of high school students in the United States indicate that the prevalence of sexual experience and most risk behaviors declined between 2001 and 2019, but fewer students reported using a condom during their last intercourse [<a href="#rid17">17,18</a>]. In the 2019 Youth Risk Behavior Survey, 38 percent of students reported that they ever had sexual intercourse (compared with 46 percent in 2001); 27 percent reported that they were currently sexually active (compared with 33 percent in 2001); 9 percent reported sexual intercourse with ≥4 persons during their life (compared with 12 percent in 2001); and 54 percent of those who were currently sexually active reported using a condom during their last intercourse (compared with 58 percent in 2001) [<a href="#rid18">18</a>].</p><p class="headingAnchor" id="H5"><span class="h2">Biologic</span><span class="headingEndMark"> — </span>Several biologic factors have been hypothesized to influence the susceptibility of adolescents to acquisition of STIs. One such factor is cervical ectopy or cervical immaturity, which refers to the area of ectocervix that is covered by columnar epithelium after puberty. Young females with immature cervical epithelium have higher levels of several cervicovaginal and regulatory cytokines and chemokines than females with mature cervical epithelium [<a href="#rid19">19</a>]. Columnar epithelium is thought to be more susceptible than squamous epithelium (that replaces columnar epithelium upon maturation) to sexually transmitted organisms such as <em>N. gonorrhoeae</em>, <em>C. trachomatis</em>, and HPV [<a href="#rid20">20</a>], although one study could not demonstrate an independent association of cervical ectopy with STIs among adolescent females [<a href="#rid21">21</a>].</p><p>Adolescents' STI susceptibility may also be influenced by the composition of the cervical and vaginal microbiome. Vaginal microbiota play an important role in vaginal immune and inflammatory responses [<a href="#rid22">22</a>]. This microbiota – especially in terms of populations of various species of <em>Lactobacillus</em> – may be particularly variable after puberty and first sexual experiences [<a href="#rid23">23,24</a>].</p><p class="headingAnchor" id="H3319674755"><span class="h2">Other risk factors</span><span class="headingEndMark"> — </span>Other risk factors for acquisition of STIs in adolescents include [<a href="#rid25">25</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Residing in a detention facility</p><p class="bulletIndent1"><span class="glyph">●</span>Mood disorders (which may increase the risk of substance use)</p><p class="bulletIndent1"><span class="glyph">●</span>Food insecurity (associated with increased risk behaviors and with STI positivity) [<a href="#rid26">26</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Adverse childhood experiences, including maltreatment, sexual abuse, and sexual trafficking [<a href="#rid27">27</a>]</p><p></p><p class="headingAnchor" id="H6"><span class="h1">SPECIFIC CONCERNS IN ADOLESCENTS</span><span class="headingEndMark"> — </span>Although the evaluation and treatment of STIs in adolescents are similar to the diagnosis and treatment of STIs in adults, a number of specific concerns are particular to adolescents, including [<a href="#rid28">28</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Consent and confidentiality</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Self-consent for diagnosis and treatment of STIs is recognized in all 50 states and the District of Columbia. However, state laws vary in terms of the specific infections defined as sexually transmitted. (See  <a class="medical medical_review" href="/d/html/105.html" rel="external">"Consent in adolescent health care", section on 'Sexually transmitted infections'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Concerns about privacy and confidentiality are important barriers to seeking medical care among adolescents with possible STIs [<a href="#rid29">29</a>]. Specific discussion of the meaning and limits of confidentiality increases disclosure of sensitive information about symptoms, sexual activity, sexual partners, and preventive behaviors [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/d/html/106.html" rel="external">"Confidentiality in adolescent health care"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patient portals in electronic health records and explanation of benefits are particular risks to adolescents' confidentiality for STI-related care. STI tests and results may be seen by parents unless systems are in place to limit access to adolescents only [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pharmacists or other medical personnel may inadvertently compromise confidentiality. A study from Indiana University shows that 30 percent of pharmacists would call parents about a prescription for antibiotics used to treat STIs [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/d/html/106.html" rel="external">"Confidentiality in adolescent health care", section on 'Potential threats to confidentiality'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pregnancy</strong> –<strong> </strong>Pregnancy or fear of pregnancy sometimes motivates care-seeking with a chief complaint of genital symptoms. (See  <a class="medical medical_review" href="/d/html/110.html" rel="external">"Pregnancy in adolescents", section on 'Diagnosis of pregnancy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sexual minoritized youth</strong> – STIs in sexual minoritized (eg, lesbian, gay, bisexual, gender diverse) youth are discussed separately. (See  <a class="medical medical_review" href="/d/html/90691.html" rel="external">"Lesbian, gay, bisexual, and other sexual minoritized youth: Epidemiology and health concerns", section on 'Sexually transmitted infections'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mandatory reporting in the United States</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Most states have "age of consent" laws that require notification of child protection authorities if sexual activity is identified, especially if there are large discrepancies in the partners' ages. Ages vary among the states. Large age discrepancies (&gt;5 years) between partners are seen in approximately one-third of adolescents with first sexual intercourse very early in adolescence (ie, ages 11 or 12 years) and in approximately one-tenth of adolescents who have their first intercourse in middle or late adolescence [<a href="#rid33">33</a>]. (See  <a class="medical medical_review" href="/d/html/106.html" rel="external">"Confidentiality in adolescent health care", section on 'Consensual sexual activity'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Reporting of some STIs is mandatory in all states, although the specific organisms vary. Syphilis, gonorrhea, and HIV/acquired immunodeficiency syndrome (AIDS) are reportable diseases in every state [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Iowa requires parental notification for HIV infection [<a href="#rid35">35</a>]; the remaining states do not require parental notification, although notification is not expressly forbidden. (See  <a class="medical medical_review" href="/d/html/106.html" rel="external">"Confidentiality in adolescent health care", section on 'Sexually transmitted infections'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dating violence</strong> – In surveys, physical and sexual violence from dating partners are reported by as many as 20 percent of adolescent females [<a href="#rid36">36,37</a>]. However, such acts are infrequently reported to clinicians; questions regarding physical and sexual dating violence should be included in clinical assessments of sexual behavior and STI risk [<a href="#rid38">38</a>].</p><p></p><p class="headingAnchor" id="H8"><span class="h1">SEXUAL HISTORY</span><span class="headingEndMark"> — </span>Routine assessment of sexual activity is an essential element of STI-related care and is endorsed by adolescents and parents/caregivers [<a href="#rid39">39,40</a>]. However, only approximately one-half of adolescents report being asked about sexual activity, and approximately one-fifth report being offered an STI test [<a href="#rid41">41</a>]. The sexual history  (<a class="graphic graphic_table graphicRef61677" href="/d/graphic/61677.html" rel="external">table 1</a>) should be straightforward and nonjudgmental, with appropriate counseling regarding risk-taking behaviors as recommended by the United States Preventive Services Task Force [<a href="#rid25">25,42</a>]. An assurance of confidentiality is an important aspect of obtaining an accurate sexual history in adolescents; additional aspects are discussed separately. (See  <a class="medical medical_review" href="/d/html/106.html" rel="external">"Confidentiality in adolescent health care"</a> and  <a class="medical medical_review" href="/d/html/113.html" rel="external">"Sexual development and sexuality in children and adolescents", section on 'Permission, privacy, and confidentiality'</a>.)</p><p class="headingAnchor" id="H2795624263"><span class="h1">SCREENING FOR STIs</span><span class="headingEndMark"> — </span>Screening for STIs in <strong>asymptomatic</strong> adolescents and young adults is discussed separately. (See  <a class="medical medical_review" href="/d/html/7596.html" rel="external">"Screening for sexually transmitted infections", section on 'Screening recommendations'</a> and  <a class="medical medical_society_guidelines" href="/d/html/111582.html" rel="external">"Society guideline links: Sexually transmitted infections"</a>.)</p><p class="headingAnchor" id="H2697270756"><span class="h1">EVALUATION FOR STIs</span><span class="headingEndMark"> — </span>Adolescents with symptoms of STI should be evaluated for STI with examination and/or diagnostic tests. The components of the examination depend upon the suspected infection.</p><p class="headingAnchor" id="H9"><span class="h2">Examination</span><span class="headingEndMark"> — </span>An external genital examination is indicated for evaluation of genital lesions that may be caused by genital herpes, primary syphilis, or human papillomavirus (HPV). Oral and anal/rectal examinations for signs of STI also are indicated based upon exposure risk.</p><p>Speculum and bimanual pelvic examinations may cause anxiety and/or discomfort and are not always necessary in the evaluation of suspected STI. Indications for speculum and bimanual pelvic examination in the evaluation of suspected STI include [<a href="#rid43">43</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal and pelvic pain and tenderness</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Obtaining specimens for STI testing, although urine or other patient-collected (eg, vaginal swabs) specimens are effective and often are preferred by adolescents [<a href="#rid44">44-51</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Associated menstrual irregularities (eg, amenorrhea unrelated to pregnancy, prolonged or heavy vaginal bleeding)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation of vaginal discharge if vaginal foreign body is suspected (eg, forgotten tampon, condom fragments, other objects)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cervical cancer screening (not routinely recommended for adolescents &lt;21 years unless they are immune compromised) (see  <a class="medical medical_review" href="/d/html/7575.html" rel="external">"Screening for cervical cancer in resource-rich settings", section on 'Age &lt;21'</a>)</p><p></p><p>The pelvic examination is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/3253.html" rel="external">"The gynecologic history and pelvic examination", section on 'Pelvic examination'</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">STI clinical patterns</span><span class="headingEndMark"> — </span>The pattern of presenting symptoms and signs guides the clinical approach to the patient with suspected STI. However, asymptomatic or minimally symptomatic presentations are common.</p><p class="headingAnchor" id="H12"><span class="h3">Discharge syndromes</span><span class="headingEndMark"> — </span>Urethral or vaginal discharge and dysuria are the hallmarks of the following STIs:</p><p class="bulletIndent1"><span class="glyph">●</span>Gonorrhea – (See  <a class="medical medical_review" href="/d/html/15893.html" rel="external">"Clinical manifestations and diagnosis of <i>Neisseria gonorrhoeae </i>infection in adults and adolescents"</a> and  <a class="medical medical_review" href="/d/html/15892.html" rel="external">"Treatment of uncomplicated gonorrhea (<i>Neisseria gonorrhoeae </i>infection) in adults and adolescents"</a> and  <a class="medical medical_review" href="/d/html/7603.html" rel="external">"Disseminated gonococcal infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chlamydia – (See  <a class="medical medical_review" href="/d/html/83019.html" rel="external">"Clinical manifestations and diagnosis of <i>Chlamydia trachomatis </i>infections"</a> and  <a class="medical medical_review" href="/d/html/7579.html" rel="external">"Treatment of <i>Chlamydia trachomatis</i> infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Trichomonas – (See  <a class="medical medical_review" href="/d/html/5453.html" rel="external">"Trichomoniasis: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bacterial vaginosis – (See  <a class="medical medical_review" href="/d/html/5451.html" rel="external">"Bacterial vaginosis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/113103.html" rel="external">"Bacterial vaginosis: Initial treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Candidiasis – (See  <a class="medical medical_review" href="/d/html/5452.html" rel="external">"Candida vulvovaginitis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/115170.html" rel="external">"Candida vulvovaginitis in adults: Treatment of acute infection"</a>.)</p><p></p><p><em>M. genitalium </em>infections are increasingly recognized as causes of sexually transmitted discharge syndromes in adolescents and young adults [<a href="#rid52">52</a>]. (See  <a class="medical medical_review" href="/d/html/83202.html" rel="external">"<i>Mycoplasma genitalium</i> infection"</a>.)</p><p>Genital herpes is sometimes associated with dysuria and a scant, mucoid urethral discharge, but nearly always in association with other genital lesions. (See  <a class="medical medical_review" href="/d/html/8347.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection"</a> and  <a class="medical medical_review" href="/d/html/8346.html" rel="external">"Treatment of genital herpes simplex virus infection"</a> and  <a class="medical medical_review" href="/d/html/8340.html" rel="external">"Genital herpes simplex virus infection and pregnancy"</a>.)</p><p>Characteristics of the discharge, such as color (eg, clear, mucoid, yellow, green), are unreliable indicators of the etiology. (See  <a class="medical medical_review" href="/d/html/5477.html" rel="external">"Vaginitis in adults: Initial evaluation"</a>.)</p><p class="headingAnchor" id="H13"><span class="h3">Genital ulcer syndrome</span><span class="headingEndMark"> — </span>Clinical features do not reliably distinguish the various cause of genital ulcer syndrome (GUS). The features of the infections associated with GUS overlap, and mixed infections occur in as many as 10 percent of cases [<a href="#rid53">53</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Causes </strong>– In the United States, genital herpes  (<a class="graphic graphic_picture graphicRef61107" href="/d/graphic/61107.html" rel="external">picture 1</a>) is the most common cause of GUS among adolescents. Symptomatic genital herpes may be caused by herpes simplex virus (HSV) type 1 in addition to the more common HSV type 2. (See  <a class="medical medical_review" href="/d/html/7592.html" rel="external">"Approach to the patient with genital ulcers"</a> and  <a class="medical medical_review" href="/d/html/8347.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection"</a>.)</p><p></p><p class="bulletIndent1">Primary syphilis is another diagnostic consideration in patients with genital ulcers  (<a class="graphic graphic_picture graphicRef75291 graphicRef57637 graphicRef73119" href="/d/graphic/75291.html" rel="external">picture 2A-C</a>), especially in young men who have sex with men and in the setting of commercial sex work or methamphetamine or cocaine use. (See  <a class="medical medical_review" href="/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent1">Less common causes of GUS in the United States, and extremely rare in adolescents, include chancroid, lymphogranuloma venereum (LGV, which occurs primarily in young men who have sex with men), and granuloma inguinale (<em>Klebsiella granulomatis</em>). (See  <a class="medical medical_review" href="/d/html/7582.html" rel="external">"Chancroid"</a> and  <a class="medical medical_review" href="/d/html/7593.html" rel="external">"Lymphogranuloma venereum"</a> and  <a class="medical medical_review" href="/d/html/7592.html" rel="external">"Approach to the patient with genital ulcers"</a>.)</p><p></p><p class="bulletIndent1">Genital ulcers are not always due to sexually transmitted organisms. Nonsexually acquired vulvar ulcers (sometimes called Lipschütz ulcers or aphthous ulcers) may occur in association with viral illness, Crohn disease, vasculitis, and Behçet syndrome  (<a class="graphic graphic_picture graphicRef68284" href="/d/graphic/68284.html" rel="external">picture 3</a>). (See  <a class="medical medical_review" href="/d/html/94795.html" rel="external">"Acute genital ulceration (Lipschütz ulcer)"</a> and  <a class="medical medical_review" href="/d/html/6450.html" rel="external">"Overview of vulvovaginal conditions in the prepubertal child", section on 'Vulvar ulcers'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – Most adolescents with GUS should be evaluated for syphilis and HSV; they should also be tested for HIV, gonorrhea, and chlamydia because patients with an ulcerative STI are at increased risk for coinfection with other STIs. Testing for chancroid, LGV, or granuloma inguinale may be indicated in patients with risk factors. (See  <a class="medical medical_review" href="/d/html/7592.html" rel="external">"Approach to the patient with genital ulcers", section on 'Diagnostic testing'</a>.)</p><p></p><p class="headingAnchor" id="H14"><span class="h3">Pelvic inflammatory disease</span><span class="headingEndMark"> — </span>Pelvic inflammatory disease (PID) refers to acute infection of the upper genital tract structures (eg, uterus, fallopian tubes, ovaries). PID encompasses a wide spectrum of clinical presentations and may be challenging to diagnose. It should be suspected in sexually active adolescents who present with pelvic discomfort, though subclinical infection may also occur. (See  <a class="medical medical_review" href="/d/html/7581.html" rel="external">"Pelvic inflammatory disease: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/7580.html" rel="external">"Pelvic inflammatory disease: Pathogenesis, microbiology, and risk factors"</a>.)</p><p>PID is a common sequela of genital gonorrhea and chlamydia infections. Douching may increase the risk, especially when performed frequently [<a href="#rid54">54</a>]. Regular douching is reported by 15 percent of adolescent females, with substantially higher proportions in some ethnic groups [<a href="#rid55">55</a>].</p><p class="headingAnchor" id="H15"><span class="h3">Dermatologic syndromes</span><span class="headingEndMark"> — </span>The most common STI with a dermatologic presentation is genital warts (condylomata acuminata) caused by HPV. HPV types 6 and 11 are the most common causes of genital warts. Anogenital warts and the epidemiology of HPV are discussed separately. (See  <a class="medical medical_review" href="/d/html/8314.html" rel="external">"Human papillomavirus infections: Epidemiology and disease associations"</a> and  <a class="medical medical_review" href="/d/html/99981.html" rel="external">"Condylomata acuminata (anogenital warts) in adults: Epidemiology, pathogenesis, clinical features, and diagnosis"</a>.)</p><p>Other STI and infections that can be transmitted by sexual activity that may present with skin rash include:</p><p class="bulletIndent1"><span class="glyph">●</span>Secondary syphilis  (<a class="graphic graphic_picture graphicRef68877" href="/d/graphic/68877.html" rel="external">picture 4</a>) (see  <a class="medical medical_review" href="/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV", section on 'Secondary syphilis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Disseminated gonococcal infection  (<a class="graphic graphic_picture graphicRef71303" href="/d/graphic/71303.html" rel="external">picture 5</a>) (see  <a class="medical medical_review" href="/d/html/7603.html" rel="external">"Disseminated gonococcal infection"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pediculosis pubis  (<a class="graphic graphic_picture graphicRef55191" href="/d/graphic/55191.html" rel="external">picture 6</a>), caused by the crab louse (see  <a class="medical medical_review" href="/d/html/4037.html" rel="external">"Pediculosis pubis and pediculosis ciliaris"</a> and  <a class="medical medical_review" href="/d/html/4038.html" rel="external">"Scabies: Epidemiology, clinical features, and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Scabies  (<a class="graphic graphic_picture graphicRef114534 graphicRef75169" href="/d/graphic/114534.html" rel="external">picture 7A-B</a>) (see  <a class="medical medical_review" href="/d/html/4037.html" rel="external">"Pediculosis pubis and pediculosis ciliaris"</a> and  <a class="medical medical_review" href="/d/html/4038.html" rel="external">"Scabies: Epidemiology, clinical features, and diagnosis"</a>)</p><p></p><p class="headingAnchor" id="H3688774454"><span class="h3">Oral lesions</span><span class="headingEndMark"> — </span>Sexually transmitted infections with oral manifestations include:</p><p class="bulletIndent1"><span class="glyph">●</span>Syphilis – Chancres are the initial manifestation of primary syphilis. They usually occur on the genitalia  (<a class="graphic graphic_picture graphicRef75291 graphicRef57637 graphicRef73119" href="/d/graphic/75291.html" rel="external">picture 2A-C</a>) but may occur on the lips, tongue, and tonsils. (See <a class="local">'Genital ulcer syndrome'</a> above and  <a class="medical medical_review" href="/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV", section on 'Primary syphilis (chancre)'</a>.)</p><p></p><p class="bulletIndent1">Mucous patches (condyloma lata), a manifestation of secondary syphilis, are characterized by large, raised gray to white lesions involving warm, moist areas such as the mucous membranes of the mouth  (<a class="graphic graphic_picture graphicRef52729 graphicRef66087" href="/d/graphic/52729.html" rel="external">picture 8A-B</a>) or perineum  (<a class="graphic graphic_picture graphicRef63924" href="/d/graphic/63924.html" rel="external">picture 9</a>). Secondary syphilis is uncommon in adolescents unless they belong to high-risk sexual networks (eg, commercial sex work, cocaine or methamphetamine users). Secondary syphilis in adolescents typically reflects delayed care-seeking for chancres. (See  <a class="medical medical_review" href="/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV", section on 'Dermatologic findings'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>N. gonorrhoeae</em> – Gonococcal pharyngitis is usually acquired by oral sexual exposure. Although most patients with gonococcal pharyngitis are asymptomatic, clinical manifestations include sore throat, pharyngeal exudates, and/or cervical lymphadenitis. (See  <a class="medical medical_review" href="/d/html/15893.html" rel="external">"Clinical manifestations and diagnosis of <i>Neisseria gonorrhoeae </i>infection in adults and adolescents", section on 'Pharyngitis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Human papillomavirus – (See  <a class="medical medical_review" href="/d/html/8314.html" rel="external">"Human papillomavirus infections: Epidemiology and disease associations", section on 'Epidemiology of oropharyngeal infection'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Herpes simplex virus – (See  <a class="medical medical_review" href="/d/html/8334.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Oral infections'</a>.)</p><p></p><p class="headingAnchor" id="H3567359482"><span class="h2">Diagnostic testing for STI</span><span class="headingEndMark"> — </span>Adolescents who are tested for STI should also receive testing and counseling for HIV infection [<a href="#rid56">56</a>]. This provides an opportunity for risk reduction education, as well as diagnosis of HIV infection. (See  <a class="medical medical_review" href="/d/html/3736.html" rel="external">"Screening and diagnostic testing for HIV infection"</a>.)</p><p>Diagnostic testing for specific STIs is discussed separately [<a href="#rid57">57</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><em>C. trachomatis</em> (see  <a class="medical medical_review" href="/d/html/83019.html" rel="external">"Clinical manifestations and diagnosis of <i>Chlamydia trachomatis </i>infections", section on 'Diagnosis of chlamydial infections'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>N. gonorrhoeae</em> (see  <a class="medical medical_review" href="/d/html/15893.html" rel="external">"Clinical manifestations and diagnosis of <i>Neisseria gonorrhoeae </i>infection in adults and adolescents", section on 'Diagnostic approach'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Syphilis (see  <a class="medical medical_review" href="/d/html/7588.html" rel="external">"Syphilis: Screening and diagnostic testing"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HIV (see  <a class="medical medical_review" href="/d/html/86984.html" rel="external">"Acute and early HIV infection: Clinical manifestations and diagnosis", section on 'Diagnosis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HSV (see  <a class="medical medical_review" href="/d/html/8347.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection", section on 'Diagnosis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chancroid (see  <a class="medical medical_review" href="/d/html/7582.html" rel="external">"Chancroid", section on 'Diagnosis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pubic lice (see  <a class="medical medical_review" href="/d/html/4037.html" rel="external">"Pediculosis pubis and pediculosis ciliaris"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>T. vaginalis</em> (see  <a class="medical medical_review" href="/d/html/5453.html" rel="external">"Trichomoniasis: Clinical manifestations and diagnosis", section on 'Diagnosis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Condylomata acuminata (see  <a class="medical medical_review" href="/d/html/99981.html" rel="external">"Condylomata acuminata (anogenital warts) in adults: Epidemiology, pathogenesis, clinical features, and diagnosis", section on 'Diagnosis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bacterial vaginosis (see  <a class="medical medical_review" href="/d/html/5451.html" rel="external">"Bacterial vaginosis: Clinical manifestations and diagnosis", section on 'Diagnostic evaluation'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vaginal candidiasis (see  <a class="medical medical_review" href="/d/html/5452.html" rel="external">"Candida vulvovaginitis: Clinical manifestations and diagnosis", section on 'Clinical evaluation'</a>)</p><p></p><p class="headingAnchor" id="H1979562712"><span class="h2">Counseling</span><span class="headingEndMark"> — </span>Adolescents who undergo diagnostic testing for STI should be counseled about STI prevention as an evidence-based clinical intervention [<a href="#rid42">42</a>]. They also should be instructed to practice abstinence while waiting for definitive test results (whether or not they receive empiric therapy). Those who are being treated for a STI (other than HIV) should be instructed to avoid sexual intercourse until they and their partner(s) have completed antimicrobial therapy [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/d/html/7595.html" rel="external">"Prevention of sexually transmitted infections", section on 'Prevention counseling'</a>.)</p><p class="headingAnchor" id="H21"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Almost no clinical trials of STI-related medications include participants younger than 16 years of age, and relatively few include 16- to 17-year-olds. Most data regarding safety and efficacy are extrapolated from late adolescents and young adults. Guidelines for the treatment of specific STIs are regularly updated by the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fstd%2Ftreatment%2Fdefault.htm&amp;token=UdAMcdIJLprxDltpT5s5Ty1p9prt2KNrJzQxHteA5LYLPMYO2ZFE1zcF56Szo11SedxWMPudFxK3jzcX2WmFNg%3D%3D&amp;TOPIC_ID=115" target="_blank">Centers for Disease Control and Prevention</a> (CDC) [<a href="#rid25">25</a>].</p><p>Additional issues related to the treatment of STIs that are particularly relevant in adolescent patients (eg, confidentiality, parental notification) are discussed above. (See <a class="local">'Specific concerns in adolescents'</a> above.)</p><p class="headingAnchor" id="H14584243"><span class="h2">Challenges to treatment</span></p><p class="headingAnchor" id="H2884442437"><span class="h3">Self-treatment</span><span class="headingEndMark"> — </span>Self-treatment with topical medications, antibiotics, or vaginal or rectal douching may delay treatment [<a href="#rid14">14,58</a>]. Symptomatic adolescent females take approximately 10 days on average to seek care compared with only approximately 6 days for symptomatic males [<a href="#rid58">58</a>].</p><p class="headingAnchor" id="H530226422"><span class="h3">Incomplete adherence</span><span class="headingEndMark"> — </span>Single-dose observed therapy is preferable when available, particularly for adolescents treated in the emergency department. In observational studies, approximately 30 to 40 percent of adolescents treated for STI in the emergency department failed to fill their prescriptions [<a href="#rid59">59,60</a>]. </p><p class="headingAnchor" id="H159743759"><span class="h3">Partner notification</span><span class="headingEndMark"> — </span>Many adolescents prefer to notify partners themselves [<a href="#rid61">61</a>]. However, this strategy means that a substantial number of partners are never notified. Because many adolescents have additional sexual contact with these partners, clinician counseling to reinforce the importance of notification and expedited partner therapy may be useful [<a href="#rid62">62-64</a>].</p><p class="headingAnchor" id="H22"><span class="h2">Expedited partner therapy</span><span class="headingEndMark"> — </span>Expedited partner therapy (EPT) refers to the provision of appropriate antibiotics to patients with STIs for delivery to partners. EPT is endorsed by the Society for Adolescent Health and Medicine and the American Academy of Pediatrics as a strategy for ensuring partner treatment [<a href="#rid65">65</a>]. Additional information is available through the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fstd%2Fept%2F&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLOYZmW8byx3T2kI8tIj4OqVGFs%2B0nqY2Jq87fKKZW58J&amp;TOPIC_ID=115" target="_blank">CDC</a>. EPT is permissible or potentially allowable in the majority of states and the District of Columbia, prohibited in few states, and varies by the type(s) of STIs covered. The Guttmacher Institute maintains a current list of <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.guttmacher.org%2Fstate-policy%2Fexplore%2Fpartner-treatment-stis&amp;token=M7EpLTvat3fFqp3Ka0JX5cHklV06JGBwDt7pGSvwWE5MwpScTQNWkFVyJhMYGavSN7%2BT3Jdki75uU9IxFxwbvDOAAm72UejD5NFlPc%2FFMR4%3D&amp;TOPIC_ID=115" target="_blank">state laws and policies</a>. Pharmacists may have little formal guidance in EPT provision from local regulatory agencies [<a href="#rid66">66</a>].</p><p class="headingAnchor" id="H23"><span class="h2">Reinfection</span><span class="headingEndMark"> — </span>A high prevalence of <em>C. trachomatis</em> and <em>N. gonorrhoeae</em> (reinfection rather than treatment failure) is observed in patients who were treated for STIs in the preceding months [<a href="#rid67">67-70</a>]. To avoid reinfection, patients and sexual partners who are being treated for an STI other than HIV should abstain from sexual activity until they have been adequately treated [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/d/html/7595.html" rel="external">"Prevention of sexually transmitted infections", section on 'Prevention counseling'</a>.)</p><p>Individuals recently treated for chlamydia or gonorrhea should be retested approximately three months after treatment is completed and whenever they next seek medical care within the following 3 to 12 months (whether or not the patient thinks that the partner was treated) [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/d/html/15892.html" rel="external">"Treatment of uncomplicated gonorrhea (<i>Neisseria gonorrhoeae </i>infection) in adults and adolescents", section on 'Retesting'</a> and  <a class="medical medical_review" href="/d/html/7579.html" rel="external">"Treatment of <i>Chlamydia trachomatis</i> infection", section on 'Retesting for all patients'</a>.)</p><p class="headingAnchor" id="H4019867602"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>Prevention of STIs is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/7595.html" rel="external">"Prevention of sexually transmitted infections"</a>.)</p><p>Routine and catch-up immunization against human papillomavirus  (<a class="graphic graphic_figure graphicRef58209" href="/d/graphic/58209.html" rel="external">figure 1</a>) and catch-up immunization (if necessary) against hepatitis B and hepatitis A  (<a class="graphic graphic_table graphicRef72079" href="/d/graphic/72079.html" rel="external">table 2</a>) are important components of STI prevention in adolescents. (See  <a class="medical medical_review" href="/d/html/2876.html" rel="external">"Standard immunizations for children and adolescents: Overview"</a>.)</p><p class="headingAnchor" id="H3558801845"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/111582.html" rel="external">"Society guideline links: Sexually transmitted infections"</a> and  <a class="medical medical_society_guidelines" href="/d/html/113065.html" rel="external">"Society guideline links: HIV infection in adolescents"</a> and  <a class="medical medical_society_guidelines" href="/d/html/117836.html" rel="external">"Society guideline links: Adolescent sexual health and pregnancy"</a>.)</p><p class="headingAnchor" id="H24"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/15914.html" rel="external">"Patient education: Teen sexuality (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/d/html/1206.html" rel="external">"Patient education: Adolescent sexuality (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H25"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Sexually transmitted infections (STIs) are common in adolescents. At least 50 percent of all new STIs occur in adolescents and young adults (age 15 to 24 years). (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Specific concerns in adolescents</strong> – Although the evaluation and treatment of STIs in adolescents are similar to the diagnosis and treatment of STIs in adults, a number of specific concerns are particular to adolescents (eg, consent and confidentiality, mandatory reporting of sexual activity and/or STI, dating violence, and challenges to optimal treatment and prevention). (See <a class="local">'Specific concerns in adolescents'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sexual history</strong> – Routine assessment of sexual activity is an essential element of STI-related care for adolescents. The sexual history  (<a class="graphic graphic_table graphicRef61677" href="/d/graphic/61677.html" rel="external">table 1</a>) should be straightforward and nonjudgmental. (See <a class="local">'Sexual history'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>STI clinical patterns</strong> – The pattern of presenting symptoms and signs of STIs can guide the need for additional information from the history, examination, and/or laboratory. (See <a class="local">'STI clinical patterns'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>STIs associated with urethral or vaginal discharge include gonorrhea, chlamydia, trichomonas, bacterial vaginosis, vulvovaginal candidiasis, <em>Mycoplasma genitalium</em>, and occasionally herpes simplex virus (HSV). (See <a class="local">'Discharge syndromes'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>STIs associated with genital ulcers in adolescents generally include HSV and primary syphilis  (<a class="graphic graphic_picture graphicRef75291" href="/d/graphic/75291.html" rel="external">picture 2A</a>). However, patients with ulcerative STI are at risk for coinfection, so most adolescents with genital ulcers should be tested for syphilis, HSV, HIV, gonorrhea, and chlamydia. (See <a class="local">'Genital ulcer syndrome'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pelvic inflammatory disease refers to acute infection of the upper genital tract structures (eg, uterus, fallopian tubes, ovaries). It should be suspected in sexually active adolescents who present with pelvic discomfort, although infection can be subclinical. (See <a class="local">'Pelvic inflammatory disease'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>STIs associated with skin lesions include genital warts caused by human papillomavirus (HPV), primary syphilis  (<a class="graphic graphic_picture graphicRef75291 graphicRef57637 graphicRef73119" href="/d/graphic/75291.html" rel="external">picture 2A-C</a>), secondary syphilis  (<a class="graphic graphic_picture graphicRef68877" href="/d/graphic/68877.html" rel="external">picture 4</a>), disseminated gonococcal infection  (<a class="graphic graphic_picture graphicRef71303" href="/d/graphic/71303.html" rel="external">picture 5</a>), pediculosis pubis, and scabies  (<a class="graphic graphic_picture graphicRef114534 graphicRef75169" href="/d/graphic/114534.html" rel="external">picture 7A-B</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>STIs associated with oral lesions include syphilis  (<a class="graphic graphic_picture graphicRef52729 graphicRef66087" href="/d/graphic/52729.html" rel="external">picture 8A-B</a>), gonorrhea, HPV, and HSV. (See <a class="local">'Oral lesions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment guidelines</strong> – Guidelines for the treatment of specific STIs are regularly updated by the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fstd%2F&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLHq8mbzWsgxDyB8T08QViwGvALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=115" target="_blank">Centers for Disease Control and Prevention</a>. (See <a class="local">'Treatment'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kreisel KM, Weston EJ, St Cyr SB, Spicknall IH. Estimates of the Prevalence and Incidence of Chlamydia and Gonorrhea Among US Men and Women, 2018. Sex Transm Dis 2021; 48:222.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2020. US Department of Health and Human Services, Atlanta, 2022. https://www.cdc.gov/std/statistics/2020/tables.htm (Accessed on April 18, 2022).</li><li><a class="nounderline abstract_t">Wikström E, Bloigu A, Ohman H, et al. An increasing proportion of reported Chlamydia trachomatis infections are repeated diagnoses. Sex Transm Dis 2012; 39:968.</a></li><li><a class="nounderline abstract_t">Fortenberry JD, Brizendine EJ, Katz BP, et al. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis. Sex Transm Dis 1999; 26:26.</a></li><li><a class="nounderline abstract_t">Tu W, Batteiger BE, Wiehe S, et al. Time from first intercourse to first sexually transmitted infection diagnosis among adolescent women. Arch Pediatr Adolesc Med 2009; 163:1106.</a></li><li><a class="nounderline abstract_t">Newbern EC, Anschuetz GL, Eberhart MG, et al. Adolescent sexually transmitted infections and risk for subsequent HIV. Am J Public Health 2013; 103:1874.</a></li><li><a class="nounderline abstract_t">Kahn JA, Rosenthal SL, Succop PA, et al. Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics 2002; 109:E5.</a></li><li><a class="nounderline abstract_t">Burstein GR, Gaydos CA, Diener-West M, et al. Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA 1998; 280:521.</a></li><li><a class="nounderline abstract_t">Fortenberry JD. Adolescent substance use and sexually transmitted diseases risk: a review. J Adolesc Health 1995; 16:304.</a></li><li><a class="nounderline abstract_t">Leigh BC. Alcohol and condom use: a meta-analysis of event-level studies. Sex Transm Dis 2002; 29:476.</a></li><li><a class="nounderline abstract_t">Niccolai LM, Ethier KA, Kershaw TS, et al. New sex partner acquisition and sexually transmitted disease risk among adolescent females. J Adolesc Health 2004; 34:216.</a></li><li><a class="nounderline abstract_t">Sauter SR, Ratnayake A, Campbell MB, Kissinger PJ. Sexual Networks and STI Infection Among Young Black Men Who Have Sex With Women in a Southern U.S. City. J Adolesc Health 2023; 72:730.</a></li><li><a class="nounderline abstract_t">Stokes ML, Abram KM, Aaby DA, et al. Substance Use Disorders and HIV/AIDS Risk Behaviors in Youth After Juvenile Detention: A 16-Year Longitudinal Study. J Adolesc Health 2023; 73:640.</a></li><li><a class="nounderline abstract_t">Hassan A, Blumenthal JS, Dube MP, et al. Effect of rectal douching/enema on rectal gonorrhoea and chlamydia among a cohort of men who have sex with men on HIV pre-exposure prophylaxis. Sex Transm Infect 2018; 94:508.</a></li><li><a class="nounderline abstract_t">Patchin JW, Hinduja S. The Nature and Extent of Sexting Among a National Sample of Middle and High School Students in the U.S. Arch Sex Behav 2019; 48:2333.</a></li><li><a class="nounderline abstract_t">Rice E, Craddock J, Hemler M, et al. Associations Between Sexting Behaviors and Sexual Behaviors Among Mobile Phone-Owning Teens in Los Angeles. Child Dev 2018; 89:110.</a></li><li><a class="nounderline abstract_t">Grunbaum JA, Kann L, Kinchen SA, et al. Youth risk behavior surveillance--United States, 2001. MMWR Surveill Summ 2002; 51:1.</a></li><li><a class="nounderline abstract_t">Szucs LE, Lowry R, Fasula AM, et al. Condom and Contraceptive Use Among Sexually Active High School Students - Youth Risk Behavior Survey, United States, 2019. MMWR Suppl 2020; 69:11.</a></li><li><a class="nounderline abstract_t">Hwang LY, Scott ME, Ma Y, Moscicki AB. Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium. J Reprod Immunol 2011; 88:66.</a></li><li><a class="nounderline abstract_t">Kleppa E, Holmen SD, Lillebø K, et al. Cervical ectopy: associations with sexually transmitted infections and HIV. A cross-sectional study of high school students in rural South Africa. Sex Transm Infect 2015; 91:124.</a></li><li><a class="nounderline abstract_t">Hwang LY, Ma Y, Moscicki AB. Biological and behavioral risks for incident Chlamydia trachomatis infection in a prospective cohort. Obstet Gynecol 2014; 124:954.</a></li><li><a class="nounderline abstract_t">Hickey RJ, Zhou X, Pierson JD, et al. Understanding vaginal microbiome complexity from an ecological perspective. Transl Res 2012; 160:267.</a></li><li><a class="nounderline abstract_t">Hickey RJ, Zhou X, Settles ML, et al. Vaginal microbiota of adolescent girls prior to the onset of menarche resemble those of reproductive-age women. MBio 2015; 6.</a></li><li><a class="nounderline abstract_t">Jespers V, Hardy L, Buyze J, et al. Association of Sexual Debut in Adolescents With Microbiota and Inflammatory Markers. Obstet Gynecol 2016; 128:22.</a></li><li><a class="nounderline abstract_t">Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021; 70:1.</a></li><li><a class="nounderline abstract_t">Nagata JM, Palar K, Gooding HC, et al. Food Insecurity, Sexual Risk, and Substance Use in Young Adults. J Adolesc Health 2021; 68:169.</a></li><li><a class="nounderline abstract_t">London S, Quinn K, Scheidell JD, et al. Adverse Experiences in Childhood and Sexually Transmitted Infection Risk From Adolescence Into Adulthood. Sex Transm Dis 2017; 44:524.</a></li><li><a class="nounderline abstract_t">Alderman EM, Breuner CC, COMMITTEE ON ADOLESCENCE. Unique Needs of the Adolescent. Pediatrics 2019; 144.</a></li><li><a class="nounderline abstract_t">Santelli JS, Klein JD, Song X, et al. Discussion of Potentially Sensitive Topics With Young People. Pediatrics 2019; 143.</a></li><li><a class="nounderline abstract_t">Gilbert AL, Rickert VI, Aalsma MC. Clinical conversations about health: the impact of confidentiality in preventive adolescent care. J Adolesc Health 2014; 55:672.</a></li><li><a class="nounderline abstract_t">Society for Adolescent Health and Medicine, Gray SH, Pasternak RH, et al. Recommendations for electronic health record use for delivery of adolescent health care. J Adolesc Health 2014; 54:487.</a></li><li><a class="nounderline abstract_t">Conard LA, Fortenberry JD, Blythe MJ, Orr DP. Pharmacists' attitudes toward and practices with adolescents. Arch Pediatr Adolesc Med 2003; 157:361.</a></li><li><a class="nounderline abstract_t">Leitenberg H, Saltzman H. A statewide survey of age at first intercourse for adolescent females and age of their male partners: relation to other risk behaviors and statutory rape implications. Arch Sex Behav 2000; 29:203.</a></li><li><a class="nounderline abstract_t">American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. ACOG Committee Opinion #301: Sexually transmitted diseases in adolescents. Obstet Gynecol 2004; 104:891.</a></li><li class="breakAll">Guttmacher Institute. State laws and policies: Minors' access to STI services. Available at: https://www.guttmacher.org/state-policy/explore/minors-access-sti-services (Accessed on May 22, 2022).</li><li><a class="nounderline abstract_t">Silverman JG, Raj A, Mucci LA, Hathaway JE. Dating violence against adolescent girls and associated substance use, unhealthy weight control, sexual risk behavior, pregnancy, and suicidality. JAMA 2001; 286:572.</a></li><li><a class="nounderline abstract_t">Wilson KM, Klein JD. Opportunities for appropriate care: health care and contraceptive use among adolescents reporting unwanted sexual intercourse. Arch Pediatr Adolesc Med 2002; 156:341.</a></li><li><a class="nounderline abstract_t">Shrier LA, Pierce JD, Emans SJ, DuRant RH. Gender differences in risk behaviors associated with forced or pressured sex. Arch Pediatr Adolesc Med 1998; 152:57.</a></li><li><a class="nounderline abstract_t">Barrow RY, Ahmed F, Bolan GA, Workowski KA. Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020. MMWR Recomm Rep 2020; 68:1.</a></li><li><a class="nounderline abstract_t">Sieving RE, McRee AL, Mehus C, et al. Sexual and Reproductive Health Discussions During Preventive Visits. Pediatrics 2021; 148.</a></li><li><a class="nounderline abstract_t">Hensel DJ, Herbenick D, Beckmeyer JJ, et al. Adolescents' Discussion of Sexual and Reproductive Health Care Topics With Providers: Findings From a Nationally Representative Probability Sample of U.S. Adolescents. J Adolesc Health 2021; 68:626.</a></li><li><a class="nounderline abstract_t">US Preventive Services Task Force, Krist AH, Davidson KW, et al. Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections: US Preventive Services Task Force Recommendation Statement. JAMA 2020; 324:674.</a></li><li><a class="nounderline abstract_t">Braverman PK, Breech L, Committee on Adolescence. American Academy of Pediatrics. Clinical report--gynecologic examination for adolescents in the pediatric office setting. Pediatrics 2010; 126:583.</a></li><li><a class="nounderline abstract_t">Cohen DA, Nsuami M, Martin DH, Farley TA. Repeated school-based screening for sexually transmitted diseases: a feasible strategy for reaching adolescents. Pediatrics 1999; 104:1281.</a></li><li><a class="nounderline abstract_t">Wiesenfeld HC, Lowry DL, Heine RP, et al. Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents. Sex Transm Dis 2001; 28:321.</a></li><li><a class="nounderline abstract_t">Serlin M, Shafer MA, Tebb K, et al. What sexually transmitted disease screening method does the adolescent prefer? Adolescents' attitudes toward first-void urine, self-collected vaginal swab, and pelvic examination. Arch Pediatr Adolesc Med 2002; 156:588.</a></li><li><a class="nounderline abstract_t">Tebb KP, Paukku MH, Pai-Dhungat MR, et al. Home STI testing: the adolescent female's opinion. J Adolesc Health 2004; 35:462.</a></li><li><a class="nounderline abstract_t">Schoeman SA, Stewart CM, Booth RA, et al. Assessment of best single sample for finding chlamydia in women with and without symptoms: a diagnostic test study. BMJ 2012; 345:e8013.</a></li><li><a class="nounderline abstract_t">Stewart CM, Schoeman SA, Booth RA, et al. Assessment of self taken swabs versus clinician taken swab cultures for diagnosing gonorrhoea in women: single centre, diagnostic accuracy study. BMJ 2012; 345:e8107.</a></li><li><a class="nounderline abstract_t">Hobbs MM, van der Pol B, Totten P, et al. From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis 2008; 35:8.</a></li><li><a class="nounderline abstract_t">Fang J, Husman C, DeSilva L, et al. Evaluation of self-collected vaginal swab, first void urine, and endocervical swab specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent females. J Pediatr Adolesc Gynecol 2008; 21:355.</a></li><li><a class="nounderline abstract_t">Tosh AK, Van Der Pol B, Fortenberry JD, et al. Mycoplasma genitalium among adolescent women and their partners. J Adolesc Health 2007; 40:412.</a></li><li><a class="nounderline abstract_t">DiCarlo RP, Martin DH. The clinical diagnosis of genital ulcer disease in men. Clin Infect Dis 1997; 25:292.</a></li><li><a class="nounderline abstract_t">Ness RB, Soper DE, Holley RL, et al. Douching and endometritis: results from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis 2001; 28:240.</a></li><li><a class="nounderline abstract_t">Merchant JS, Oh K, Klerman LV. Douching: a problem for adolescent girls and young women. Arch Pediatr Adolesc Med 1999; 153:834.</a></li><li><a class="nounderline abstract_t">Petsis D, Min J, Huang YV, et al. HIV Testing Among Adolescents With Acute Sexually Transmitted Infections. Pediatrics 2020; 145.</a></li><li><a class="nounderline abstract_t">Gaydos CA, Manabe YC, Melendez JH. A Narrative Review of Where We Are With Point-of-Care Sexually Transmitted Infection Testing in the United States. Sex Transm Dis 2021; 48:S71.</a></li><li><a class="nounderline abstract_t">Fortenberry JD. Health care seeking behaviors related to sexually transmitted diseases among adolescents. Am J Public Health 1997; 87:417.</a></li><li><a class="nounderline abstract_t">Schneider K, Byczkowski T, Reed J. Treatment Compliance Among Asymptomatic Adolescents With Sexually Transmitted Infections. JAMA Pediatr 2015; 169:1065.</a></li><li><a class="nounderline abstract_t">Lieberman A, Badolato GM, Tran J, Goyal MK. Frequency of Prescription Filling Among Adolescents Prescribed Treatment for Sexually Transmitted Infections in the Emergency Department. JAMA Pediatr 2019; 173:695.</a></li><li><a class="nounderline abstract_t">Oh MK, Boker JR, Genuardi FJ, et al. Sexual contact tracing outcome in adolescent chlamydial and gonococcal cervicitis cases. J Adolesc Health 1996; 18:4.</a></li><li><a class="nounderline abstract_t">Fortenberry JD, Brizendine EJ, Katz BP, Orr DP. Post-treatment sexual and prevention behaviours of adolescents with sexually transmitted infections. Sex Transm Infect 2002; 78:365.</a></li><li><a class="nounderline abstract_t">Fortenberry JD, Brizendine EJ, Katz BP, Orr DP. The role of self-efficacy and relationship quality in partner notification by adolescents with sexually transmitted infections. Arch Pediatr Adolesc Med 2002; 156:1133.</a></li><li><a class="nounderline abstract_t">Niccolai LM, Ickovics JR, Zeller K, et al. Knowledge of sex partner treatment for past bacterial STI and risk of current STI. Sex Transm Infect 2005; 81:271.</a></li><li><a class="nounderline abstract_t">Burstein GR, Eliscu A, Ford K, et al. Expedited partner therapy for adolescents diagnosed with chlamydia or gonorrhea: a position paper of the Society for Adolescent Medicine. J Adolesc Health 2009; 45:303.</a></li><li><a class="nounderline abstract_t">Carman-McClanahan M, McCool-Myers M. Guidance on Expedited Partner Therapy: A Content Analysis of Informational Materials for Providers, Pharmacists, Patients, and Partners. Sex Transm Dis 2020; 47:136.</a></li><li><a class="nounderline abstract_t">Kjaer HO, Dimcevski G, Hoff G, et al. Recurrence of urogenital Chlamydia trachomatis infection evaluated by mailed samples obtained at home: 24 weeks' prospective follow up study. Sex Transm Infect 2000; 76:169.</a></li><li><a class="nounderline abstract_t">Whittington WL, Kent C, Kissinger P, et al. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis 2001; 28:117.</a></li><li><a class="nounderline abstract_t">Oh MK, Cloud GA, Fleenor M, et al. Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study. J Adolesc Health 1996; 18:270.</a></li><li><a class="nounderline abstract_t">Thomas JC, Weiner DH, Schoenbach VJ, Earp JA. Frequent re-infection in a community with hyperendemic gonorrhoea and chlamydia: appropriate clinical actions. Int J STD AIDS 2000; 11:461.</a></li></ol></div><div id="topicVersionRevision">Topic 115 Version 70.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33492094" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Estimates of the Prevalence and Incidence of Chlamydia and Gonorrhea Among US Men and Women, 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33492094" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Estimates of the Prevalence and Incidence of Chlamydia and Gonorrhea Among US Men and Women, 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23191952" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : An increasing proportion of reported Chlamydia trachomatis infections are repeated diagnoses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9918320" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19996047" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Time from first intercourse to first sexually transmitted infection diagnosis among adolescent women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23947325" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Adolescent sexually transmitted infections and risk for subsequent HIV.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11773573" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9707141" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Incident Chlamydia trachomatis infections among inner-city adolescent females.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7612636" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Adolescent substance use and sexually transmitted diseases risk: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12172533" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Alcohol and condom use: a meta-analysis of event-level studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14967345" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : New sex partner acquisition and sexually transmitted disease risk among adolescent females.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36599759" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Sexual Networks and STI Infection Among Young Black Men Who Have Sex With Women in a Southern U.S. City.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37716716" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Substance Use Disorders and HIV/AIDS Risk Behaviors in Youth After Juvenile Detention: A 16-Year Longitudinal Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29907624" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Effect of rectal douching/enema on rectal gonorrhoea and chlamydia among a cohort of men who have sex with men on HIV pre-exposure prophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31309428" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The Nature and Extent of Sexting Among a National Sample of Middle and High School Students in the U.S.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28556896" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Associations Between Sexting Behaviors and Sexual Behaviors Among Mobile Phone-Owning Teens in Los Angeles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12102329" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Youth risk behavior surveillance--United States, 2001.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32817600" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Condom and Contraceptive Use Among Sexually Active High School Students - Youth Risk Behavior Survey, United States, 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21051089" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25281761" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Cervical ectopy: associations with sexually transmitted infections and HIV. A cross-sectional study of high school students in rural South Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25437724" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Biological and behavioral risks for incident Chlamydia trachomatis infection in a prospective cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22683415" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Understanding vaginal microbiome complexity from an ecological perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25805726" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Vaginal microbiota of adolescent girls prior to the onset of menarche resemble those of reproductive-age women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27275789" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Association of Sexual Debut in Adolescents With Microbiota and Inflammatory Markers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34292926" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Sexually Transmitted Infections Treatment Guidelines, 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32682597" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Food Insecurity, Sexual Risk, and Substance Use in Young Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28809769" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Adverse Experiences in Childhood and Sexually Transmitted Infection Risk From Adolescence Into Adulthood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31740496" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Unique Needs of the Adolescent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30651304" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Discussion of Potentially Sensitive Topics With Young People.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25043835" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Clinical conversations about health: the impact of confidentiality in preventive adolescent care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24656534" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Recommendations for electronic health record use for delivery of adolescent health care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12695232" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Pharmacists' attitudes toward and practices with adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10992978" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : A statewide survey of age at first intercourse for adolescent females and age of their male partners: relation to other risk behaviors and statutory rape implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15458917" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : ACOG Committee Opinion #301: Sexually transmitted diseases in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15458917" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : ACOG Committee Opinion #301: Sexually transmitted diseases in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11476659" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Dating violence against adolescent girls and associated substance use, unhealthy weight control, sexual risk behavior, pregnancy, and suicidality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11929367" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Opportunities for appropriate care: health care and contraceptive use among adolescents reporting unwanted sexual intercourse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9452709" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Gender differences in risk behaviors associated with forced or pressured sex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31899459" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34253569" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Sexual and Reproductive Health Discussions During Preventive Visits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32788074" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Adolescents' Discussion of Sexual and Reproductive Health Care Topics With Providers: Findings From a Nationally Representative Probability Sample of U.S. Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32809008" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20805151" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : American Academy of Pediatrics. Clinical report--gynecologic examination for adolescents in the pediatric office setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10585978" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Repeated school-based screening for sexually transmitted diseases: a feasible strategy for reaching adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11403188" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12038892" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : What sexually transmitted disease screening method does the adolescent prefer? Adolescents' attitudes toward first-void urine, self-collected vaginal swab, and pelvic examination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15581525" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Home STI testing: the adolescent female's opinion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23236032" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Assessment of best single sample for finding chlamydia in women with and without symptoms: a diagnostic test study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23236033" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Assessment of self taken swabs versus clinician taken swab cultures for diagnosing gonorrhoea in women: single centre, diagnostic accuracy study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18157061" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19064231" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Evaluation of self-collected vaginal swab, first void urine, and endocervical swab specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent females.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17448398" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Mycoplasma genitalium among adolescent women and their partners.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9332527" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : The clinical diagnosis of genital ulcer disease in men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11318257" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Douching and endometritis: results from the PID evaluation and clinical health (PEACH) study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10437756" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Douching: a problem for adolescent girls and young women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32179661" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : HIV Testing Among Adolescents With Acute Sexually Transmitted Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34110728" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : A Narrative Review of Where We Are With Point-of-Care Sexually Transmitted Infection Testing in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9096544" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Health care seeking behaviors related to sexually transmitted diseases among adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26389718" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Treatment Compliance Among Asymptomatic Adolescents With Sexually Transmitted Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31135829" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Frequency of Prescription Filling Among Adolescents Prescribed Treatment for Sexually Transmitted Infections in the Emergency Department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8750422" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Sexual contact tracing outcome in adolescent chlamydial and gonococcal cervicitis cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12407242" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Post-treatment sexual and prevention behaviours of adolescents with sexually transmitted infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12413343" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The role of self-efficacy and relationship quality in partner notification by adolescents with sexually transmitted infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15923301" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Knowledge of sex partner treatment for past bacterial STI and risk of current STI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19699429" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Expedited partner therapy for adolescents diagnosed with chlamydia or gonorrhea: a position paper of the Society for Adolescent Medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31935209" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Guidance on Expedited Partner Therapy: A Content Analysis of Informational Materials for Providers, Pharmacists, Patients, and Partners.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10961191" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Recurrence of urogenital Chlamydia trachomatis infection evaluated by mailed samples obtained at home: 24 weeks' prospective follow up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11234786" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8860791" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10919489" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Frequent re-infection in a community with hyperendemic gonorrhoea and chlamydia: appropriate clinical actions.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
